Article
MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
PloS one - 1 Jan 2013
Ma Yong, Bian Jianmin, Cao Hongyong
Abstract excerpt
BACKGROUND: MDM2 is a major negative regulator of p53, and a single nucleotide polymorphism (SNP) in the MDM2 promoter region SNP309 has been demonstrated to be associated with an increased MDM2 expression and a significantly earlier age of onset of several tumors, including gastric cancer. Several studies were published to evaluate the association between SNP309 and gastric cancer risk. However, the results...
Topics
- Case-Control Studies
- Genetic Predisposition to Disease
- Humans
- Odds Ratio
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins c-mdm2
- Stomach Neoplasms
